Submissions from 2017
A phase 3 randomized controlled clinical trial of bictegravir in a fixed dose combination, B/F/TAF, vs ABC/DTG/3TC in treatment-naive adults at Week 48, J Gallant, A Lazzarin, A Mills, C Orkin, D Podzamczer, P Tebas, P M. Girard, Indira Brar, E Daar, D Wohl, J Rockstroh, X Wei, K White, H Martin, E Quirk, and A Cheng
Utilization of interferon gamma release assays (IGRAs) for the detection of latent tuberculosis infection (LTBI) at a tertiary care hospital, G M. Molina-Pallete, J Kansagra, and Indira Brar
Submissions from 2016
Risk factors for single and recurrent symptomatic urinary tract infections within the first year after kidney transplantation, K Bourgi, W Choi, A Nakhle, Z Abdel-Rahman, Odaliz Abreu-Lanfranco, Mayur Ramesh, A Patel, Ramon Del Busto, and George Alangaden
Chronic necrotizing aspergillosis, Jeremy Gentile and Anne Chen
Emotional motivators: Using visual triggers as an infection control intervention to increase hand hygiene compliance throughout the hospital, Ashley Gregory, Eman Chami, and Jennifer J. Pietsch
Successful outcomes of fecal microbiota transplantation in patients with chronic liver disease, Alireza Meighani, Mayur Ramesh, and Reena Salgia
Submissions from 2015
Infection in the “fifth valve” of the heart, Suraj Raheja and Marcus Zervos
